Adsorptive Depletion of α4 Integrinhi- and CX3CR1hi-Expressing Proinflammatory Monocytes in Patients with Ulcerative Colitis

被引:10
作者
Takeda, Shin-ichiro [1 ]
Sato, Toru [1 ]
Katsuno, Tatsuro [1 ]
Nakagawa, Tomoo [1 ]
Noguchi, Yoshiko [1 ]
Yokosuka, Osamu [2 ]
Saito, Yasushi [1 ]
机构
[1] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol F5, Chuo Ku, Chiba 2608670, Japan
[2] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol K1, Chuo Ku, Chiba 2608670, Japan
关键词
Ulcerative colitis; CD14(+)CD16(+) monocytes; CD14(hi)CD16(-)CCR2(low) monocytes; alpha; 4; Integrin; CX(3)CR1; Adsorptive depletion of myeloid leucocytes; INFLAMMATORY-BOWEL-DISEASE; INTERLEUKIN-1 RECEPTOR ANTAGONIST; SELECTIVE LEUKOCYTE APHERESIS; STEROID NAIVE PATIENTS; GRANULOCYTE/MONOCYTE APHERESIS; CLINICAL-RESPONSE; CD14(+)CD16(+)DR(++) MONOCYTES; PERIPHERAL-BLOOD; BONE-MARROW; THERAPY;
D O I
10.1007/s10620-009-0974-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Two main functionally distinct monocytes phenotypes are known: the CD14(hi)CD16(-) "classical" and the CD14(+)CD16(+) "proinflammatory" phenotypes. The latter phenotype is elevated in patients with ulcerative colitis (UC) and is suspected to have a major role in the immunopathogenesis of UC. To selectively deplete circulating proinflammatory CD14(+)CD16(+) monocyte phenotype. Seven corticosteroid-na < ve patients with UC (clinical activity index = 8.7 +/- A 1.3) and seven healthy subjects were included. In patients with UC, granulocyte/monocyte adsorption (GMA) was done with an Adacolumn that selectively adsorbs leucocytes of the myeloid lineage. Blood from all subjects at baseline and from the patients immediately after the first GMA session was processed. Isolated monocytes were subjected to fluorescence-activated cell sorter analyses. The seven UC patients achieved remission (CAI a parts per thousand currency sign4) after 5-10 GMA sessions. GMA induced a strong fall in the ratio (%) of CD14(+)CD16(+) to CD14(hi)CD16(-) monocytes, from 10.0 +/- A 1.4 to 3.0 +/- A 0.9. Further, expressions of alpha 4 integrin (374.8 +/- A 26.1 mean fluorescence intensity, MFI) and CX(3)CR1 (49.5 +/- A 4.6 MFI) were significantly high on CD14(+)CD16(+)monocytes as compared with on CD14(hi)CD16(-) monocytes (169.2 +/- A 17.2 and 33.2 +/- A 3.6 MFI, respectively). Additionally, GMA significantly increased the ratio of the CD14(hi)CD16(-)CCR2(low) "immature" monocytes from 3.74 +/- A 0.62 to 8.11 +/- A 0.56 MFI. We found high expressions of alpha 4 integrin and CX(3)CR1 on monocytes in patients with active UC, known to promote the extravasation of CD14(+)CD16(+) monocytes into the mucosa. GMA effectively depletes CD14(+)CD16(+) monocytes and concomitantly increases CD14(hi)CD16(-)CCR2(low) "immature" monocytes; thus GMA was associated with the emergence of less inflammatory monocyte phenotype in circulation.
引用
收藏
页码:1886 / 1895
页数:10
相关论文
共 57 条
[1]
Selective leukocyte apheresis for the treatment of inflammatory bowel disease [J].
Abreu, Maria T. ;
Plevy, Scott ;
Sands, Bruce E. ;
Weinstein, Robert .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (10) :874-888
[2]
ALLISON MC, 1998, INFLAMM BOWEL DIS, P15
[3]
Fractalkine preferentially mediates arrest and migration of CD16+ monocytes [J].
Ancuta, P ;
Rao, R ;
Moses, A ;
Mehle, A ;
Shaw, SK ;
Luscinskas, FW ;
Gabuzda, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12) :1701-1707
[4]
Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis [J].
Andoh, A ;
Tsujikawa, T ;
Inatomi, O ;
Deguchi, Y ;
Hata, K ;
Kitoh, K ;
Sasaki, M ;
Mitsuyama, K ;
Fujiyama, Y .
THERAPEUTIC APHERESIS AND DIALYSIS, 2005, 9 (02) :123-127
[5]
Adacolumn selective leukocyte adsorption apheresis in patients with active ulcerative colitis: Clinical efficacy, effects on plasma IL-8, and expression of toll-like receptor 2 on granulocytes [J].
Aoki, Hiroshi ;
Nakamura, Kentaro ;
Yoshimatsu, Yasushi ;
Tsuda, Yukiko ;
Irie, Masaki ;
Fukuda, Katsuyuki ;
Hosoe, Nobuo ;
Takada, Nobuo ;
Shirai, Koji ;
Suzuki, Yasuo .
DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (06) :1427-1433
[6]
Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology [J].
Baumgart, Daniel C. ;
Carding, Simon R. .
LANCET, 2007, 369 (9573) :1627-1640
[7]
Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies [J].
Baumgart, Daniel C. ;
Sandborn, William J. .
LANCET, 2007, 369 (9573) :1641-1657
[8]
The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF [J].
Belge, KU ;
Dayyani, F ;
Horelt, A ;
Siedlar, M ;
Frankenberger, M ;
Frankenberger, B ;
Espevik, T ;
Ziegler-Heitbrock, L .
JOURNAL OF IMMUNOLOGY, 2002, 168 (07) :3536-3542
[9]
Treatment of patients with acute ulcerative colitis: Conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): A pilot study [J].
Bresci, G. ;
Parisi, G. ;
Mazzoni, A. ;
Scatena, F. ;
Capria, A. .
DIGESTIVE AND LIVER DISEASE, 2007, 39 (05) :430-434
[10]
Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis [J].
Cuadrado, Emilio ;
Alonso, Marta ;
de Juan, Maria Dolores ;
Echaniz, Pilar ;
Arenas, Juan Ignacio .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (10) :1521-1527